期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

2009年 第3卷 第1期

摘要

关键词

相关研究

回顶部

《医学前沿（英文）》 >> 2009年 第3卷 第1期 doi: 10.1007/s11684-009-0017-6

Protein phosphatase 2A, a key player in Alzheimer’s disease

Department of Pathophysiology, Hubei Provincial Key Laboratory of Neurological Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

发布日期： 2009-03-05
HTML25 PDF 3 收藏 0

下一篇 上一篇

摘要

Protein phosphatase 2A (PP2A) is the predominant serine/threonine phosphatase in eukaryotic cells. In the brains of patients with Alzheimer’s disease (AD), decreased PP2A activities were observed, which is suggested to be involved in neurofibrillary tangle (NFT) formation, disturbed amyloid precursor protein (APP) secretion and neurodegeneration in AD brain. Based on our research and other previous findings, decreased PP2Ac level, decreased PP2A holoenzyme composition, increased level of PP2A inhibitors, increased PP2Ac Leu309 demethylation and Tyr307 phosphorylation underlie PP2A inactivation in AD. β-amyloid (Aβ) over-production, estrogen deficiency and impaired homocysteine metabolism are the possible up-stream factors that inactivate PP2A in AD neurons. Further studies are required to disclose the role of PP2A in Alzheimer’s disease.

相关研究